• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

普萘洛尔和索他洛尔通过人胎盘的转运及其对母体和胎儿血浆肾素活性的影响。

Transfer of propranolol and sotalol across the human placenta. Their effect on maternal and fetal plasma renin activity.

作者信息

Erkkola R, Lammintausta R, Liukko P, Anttila M

出版信息

Acta Obstet Gynecol Scand. 1982;61(1):31-4. doi: 10.3109/00016348209156947.

DOI:10.3109/00016348209156947
PMID:7046334
Abstract

Eighty milligrams of propranolol or sotalol was administered orally to two groups of 8 parturients who were to undergo elective cesarean section. This was performed 3 hours after drug administration. The transplacental passage of both drugs was registered in each patient. The maternal concentration of propranolol was approximately four times that in the umbilical circulation, while the sotalol level in maternal circulation was twice that in the umbilical circulation. The administration of beta-adrenoceptor antagonists caused a significant decrease in maternal plasma renin activity. After these doses of beta blockers, no difference in the plasma renin activity was found in the umbilical circulation, when compared with the previous normal values at cesarean section.

摘要

给两组各8名计划进行择期剖宫产的产妇口服80毫克普萘洛尔或索他洛尔。给药3小时后进行剖宫产。记录每位患者中两种药物的经胎盘转运情况。普萘洛尔的母体浓度约为脐循环浓度的四倍,而索他洛尔在母体循环中的水平是脐循环中的两倍。β肾上腺素能受体拮抗剂的给药导致母体血浆肾素活性显著降低。给予这些剂量的β受体阻滞剂后,与剖宫产时先前的正常值相比,脐循环中的血浆肾素活性未发现差异。

相似文献

1
Transfer of propranolol and sotalol across the human placenta. Their effect on maternal and fetal plasma renin activity.普萘洛尔和索他洛尔通过人胎盘的转运及其对母体和胎儿血浆肾素活性的影响。
Acta Obstet Gynecol Scand. 1982;61(1):31-4. doi: 10.3109/00016348209156947.
2
Transfer of beta blocking drugs from the amniotic fluid to the fetal and maternal circulation.β受体阻滞剂从羊水向胎儿及母体循环的转运。
J Pharmacol Exp Ther. 1978 Nov;207(2):641-9.
3
Sotalol as a hypotensive agent in pregnancy.索他洛尔作为妊娠期降压药物。
Br J Obstet Gynaecol. 1980 Sep;87(9):814-20. doi: 10.1111/j.1471-0528.1980.tb04618.x.
4
Maternal and fetal plasma renin activity during ritodrine infusion to the mother.母亲输注利托君期间母胎血浆肾素活性
Biol Neonate. 1979;35(5-6):268-72. doi: 10.1159/000241185.
5
Treatment of fetal tachycardia with sotalol: transplacental pharmacokinetics and pharmacodynamics.索他洛尔治疗胎儿心动过速:经胎盘的药代动力学和药效学
J Am Coll Cardiol. 2003 Aug 20;42(4):765-70. doi: 10.1016/s0735-1097(03)00779-4.
6
Plasma renin activity in the intervillous space of the human placenta, in umbilical vessels and in maternal peripheral venous blood.
Rev Bras Pesqui Med Biol. 1978 Jun;11(2-3):141-4.
7
Pharmacokinetics of propranolol and sotalol in hyperthyroidism.普萘洛尔和索他洛尔在甲状腺功能亢进症中的药代动力学。
Eur J Clin Pharmacol. 1982;21(5):373-7. doi: 10.1007/BF00542321.
8
Uteroplacental unit as a source of elevated circulating prorenin levels in normal pregnancy.
Am J Obstet Gynecol. 1986 Dec;155(6):1223-6. doi: 10.1016/0002-9378(86)90148-1.
9
Plasma clearance of propranolol and sotalol and hepatic drug-metabolizing enzyme activity.
Clin Pharmacol Ther. 1979 Aug;26(2):153-61. doi: 10.1002/cpt1979262153.
10
Propranolol therapy during pregnancy, labor, and delivery: evidence for transplacental drug transfer and impaired neonatal drug disposition.孕期、分娩期使用普萘洛尔治疗:经胎盘药物转运及新生儿药物代谢受损的证据
J Pediatr. 1977 Nov;91(5):812-4. doi: 10.1016/s0022-3476(77)81049-4.

引用本文的文献

1
The Risk for Neonatal Hypoglycemia and Bradycardia after Beta-Blocker Use during Pregnancy or Lactation: A Systematic Review and Meta-Analysis.β受体阻滞剂在妊娠或哺乳期使用后致新生儿低血糖和心动过缓的风险:系统评价和荟萃分析。
Int J Environ Res Public Health. 2022 Aug 4;19(15):9616. doi: 10.3390/ijerph19159616.
2
Management of fetal tachyarrhythmia based on superior vena cava/aorta Doppler flow recordings.基于上腔静脉/主动脉多普勒血流记录的胎儿心动过速管理。
Heart. 2003 Oct;89(10):1211-6. doi: 10.1136/heart.89.10.1211.
3
Drug treatment of fetal tachycardias.
胎儿心动过速的药物治疗。
Paediatr Drugs. 2002;4(1):49-63. doi: 10.2165/00128072-200204010-00006.
4
Placental transfer of drugs administered to the mother.药物经母体的胎盘转运
Clin Pharmacokinet. 1995 Mar;28(3):235-69. doi: 10.2165/00003088-199528030-00005.
5
Models for placental transfer studies of drugs.药物胎盘转运研究模型。
Clin Pharmacokinet. 1995 Feb;28(2):161-80. doi: 10.2165/00003088-199528020-00006.
6
Sotalol. An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmias.索他洛尔。其药理特性及在心律失常治疗应用中的最新综述。
Drugs. 1993 Oct;46(4):678-719. doi: 10.2165/00003495-199346040-00007.
7
Hypertension in pregnancy. Pathophysiology and management.妊娠期高血压。病理生理学与管理
Drugs. 1984 Aug;28(2):170-88. doi: 10.2165/00003495-198428020-00005.
8
Sotalol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.索他洛尔。对其药效学和药代动力学特性以及治疗用途的综述。
Drugs. 1987 Sep;34(3):311-49. doi: 10.2165/00003495-198734030-00002.
9
The effect of enalapril (MK421), an angiotensin converting enzyme inhibitor, on the conscious pregnant ewe and her foetus.血管紧张素转换酶抑制剂依那普利(MK421)对清醒妊娠母羊及其胎儿的影响。
Br J Pharmacol. 1986 Mar;87(3):533-42. doi: 10.1111/j.1476-5381.1986.tb10195.x.